49,711 Shares in Azenta, Inc. $AZTA Acquired by Magnetar Financial LLC

Key Points

• Magnetar Financial LLC has made a new investment in Azenta, Inc., acquiring approximately $1.72 million for a total of 49,711 shares.
• Other institutional investors have significantly increased their stakes in Azenta, with Farther Finance Advisors LLC boosting its holdings by 788.1%.
• Azenta reported earnings of $0.19 EPS, exceeding analysts' expectations of $0.13 per share, despite a decrease in revenue compared to consensus estimates.

Magnetar Financial LLC purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 49,711 shares of the company's stock, valued at approximately $1,722,000. Magnetar Financial LLC owned about 0.11% of Azenta as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Deutsche Bank AG increased its stake in Azenta by 28.5% in the fourth quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after purchasing an additional 931 shares during the period. SG Americas Securities LLC increased its stake in Azenta by 90.6% in the 1st quarter. SG Americas Securities LLC now owns 30,972 shares of the company's stock worth $1,073,000 after buying an additional 14,719 shares during the period. Principal Financial Group Inc. lifted its holdings in Azenta by 2.4% during the 1st quarter. Principal Financial Group Inc. now owns 226,491 shares of the company's stock valued at $7,846,000 after buying an additional 5,408 shares in the last quarter. Corton Capital Inc. purchased a new stake in Azenta in the 4th quarter valued at about $295,000. Finally, Boothbay Fund Management LLC grew its stake in Azenta by 8.4% in the 4th quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock worth $329,000 after acquiring an additional 509 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Azenta Trading Down 0.4%

Shares of NASDAQ:AZTA traded down $0.11 during trading on Thursday, reaching $29.27. The stock had a trading volume of 450,242 shares, compared to its average volume of 752,149. The firm's 50-day simple moving average is $31.37 and its 200 day simple moving average is $31.84. Azenta, Inc. has a one year low of $23.91 and a one year high of $55.63. The company has a market capitalization of $1.34 billion, a P/E ratio of -12.08 and a beta of 1.65.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.13 by $0.06. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The firm had revenue of $143.94 million during the quarter, compared to analyst estimates of $149.64 million. During the same quarter in the previous year, the business posted $0.14 EPS. Azenta's revenue was up .0% on a year-over-year basis. Equities research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AZTA has been the subject of several research analyst reports. Evercore ISI set a $33.00 price target on shares of Azenta and gave the company an "in-line" rating in a research note on Tuesday, August 5th. Needham & Company LLC lowered their target price on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Raymond James Financial upgraded Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 price target on the stock in a research note on Wednesday, August 6th. Finally, Stephens started coverage on Azenta in a report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 price objective for the company. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $35.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.